Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Calcitonin treatment for neuropathic pain after spinal cord injury

Official title: Effect of Early Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury

Run by Tanta University · NCT05805683 · Data updated 2026-11-12

This study is testing if calcitonin can help reduce the pain that people experience after a spinal cord injury compared to a placebo.

More Spinal Cord Injury trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment126 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, Gharbia Governorate)
StatusRecruiting
StartedMay 1, 2023
Main results expectedMay 1, 2027
Study endsMay 1, 2028
Registry record updatedMay 14, 2026
Trial IDNCT05805683 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who have sustained a spinal cord injury at any level and degree of completeness shortly after the trauma.

Probably not a fit

Patients who are currently taking anticonvulsants, have existing neuropathic pain, or have a history of allergic reactions to calcitonin may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective randomized double-blinded study aims to evaluate the effects of early calcitonin treatment on the incidence and severity of neuropathic pain following spinal cord injury. The study will categorize pain into various types and assess how calcitonin, known for its effectiveness in managing acute pain in other conditions, can help in this context. Participants will be randomly assigned to receive either calcitonin or a placebo, allowing for a controlled comparison of outcomes.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce the incidence and severity of neuropathic pain in patients with spinal cord injuries.

How similar studies have gone: Previous studies have shown calcitonin to be effective in managing acute pain in various conditions, suggesting potential for success in this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged ≥18 years, with spinal cord injury at any level and any degree of completeness in the early stage of trauma.

Exclusion Criteria:

* Intake of anticonvulsants medications.
* Evidence of neuropathic pain.
* Evidence of previous allergic reaction to calcitonin.
* Patients with renal, hepatic and cardiac dysfunction or neurological disorders .
* brain damage or major trauma to extremities or abdomen.

Where it's running

  • Tanta University
    Tanta, Gharbia Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.